Search research articles
Contact Us
Filters
Showing results (141-150 of 154) with videos related to
Page
of 16
Sort By:
Plos One
|
October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis
Rennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
ERJ Open Research
|
August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma
Matthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Arthritis Research & Therapy
|
August 29, 2014
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Glynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2021
Racial/ethnic differences in eligibility for asthma biologics among pediatric populations
Eric M Wohlford, Peter F Huang, Jennifer R Elhawary, et al.
Scientific Reports
|
April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma risk
Diana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes
P Jane McDowell, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex
Matthew C Eastwood, John Busby, David J Jackson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
Chest
|
February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers
Sebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
The European Respiratory Journal
|
September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma
John Busby, John G Matthews, Rekha Chaudhuri, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 154) with videos related to
Sort By:
Page
of 16
Plos One
|
October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis
Rennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
ERJ Open Research
|
August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma
Matthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Arthritis Research & Therapy
|
August 29, 2014
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Glynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2021
Racial/ethnic differences in eligibility for asthma biologics among pediatric populations
Eric M Wohlford, Peter F Huang, Jennifer R Elhawary, et al.
Scientific Reports
|
April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma risk
Diana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes
P Jane McDowell, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex
Matthew C Eastwood, John Busby, David J Jackson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
Chest
|
February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers
Sebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
The European Respiratory Journal
|
September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma
John Busby, John G Matthews, Rekha Chaudhuri, et al.
Page
of 16